Angiodynamics (ANGO) Cash from Investing Activities (2010 - 2026)

Angiodynamics has reported Cash from Investing Activities for 17 years, with the latest figure at -$1.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities rose 52.74% year-over-year to -$1.5 million; the trailing twelve-month figure through Feb 2026 stood at -$7.3 million (up 26.18% YoY), and the FY2025 full-year result was -$10.2 million, down 108.23% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$1.5 million, up from -$1.6 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $98.4 million in Q3 2023, with the low at -$3.8 million in Q2 2022.
• Historically, Cash from Investing Activities has averaged $5.5 million across 5 years, with a median of -$2.1 million in 2023.
• Annual changes were most pronounced in 2023 — Cash from Investing Activities jumped 2852.85% — and 2025, when it slumped 110.85%.
• Angiodynamics' Cash from Investing Activities stood at -$2.5 million in 2022, then advanced by 28.17% to -$1.8 million in 2023, then retreated by 9.37% to -$2.0 million in 2024, then advanced by 17.34% to -$1.6 million in 2025, then rose by 7.03% to -$1.5 million in 2026.
• The last three Cash from Investing Activities figures came in at -$1.5 million (Q1 2026), -$1.6 million (Q4 2025), and -$1.6 million (Q3 2025), per Business Quant data.